PCOS and Hair Loss: Why It Happens and What Can Help

If your part looks wider or your hair feels thinner than it used to, you’re far from alone. Hair loss is one of the less-discussed signs of PCOS, and for many women, PCOS hair loss is one of the hardest to live with, partly because it’s so often brushed off as “just hormones” without any explanation of which hormones, why they reach your scalp, or what can be done.

The short version is that it usually comes down to how sensitive your hair follicles are to androgens, hormones like testosterone that everyone has but that tend to run higher in PCOS. This article walks through why that happens, how to tell it apart from other causes of shedding, what each treatment actually does, and when it’s worth seeing a doctor.

A quick note on terms: in May 2026, PCOS was officially renamed polyendocrine metabolic ovarian syndrome (PMOS), and both names will be used for about three years. We’ll say PCOS here because it’s still what most people search for.

Why PCOS can cause hair loss

Androgens and your hair follicles

Every hair on your head grows from a follicle, a tiny pocket in your skin. Each follicle cycles through a growing phase, a short transition, and a resting phase that lasts a few months, after which the hair sheds and a new one begins, as a review of hair shedding and Harvard Health both describe.

Androgens can change that cycle in some follicles. Your body converts part of its testosterone into a stronger form called DHT, and in follicles that are sensitive to it, DHT shortens the growing phase. Each new hair then has less time to grow, so it comes in finer and shorter than the one before. Over time, those follicles produce hairs so fine they barely show, and the scalp becomes more visible. This gradual shrinking is called miniaturization.

It typically shows up as thinning over the crown and along the part, while the hairline at the front stays in place and the back of the scalp is usually spared.

This pattern is called female pattern hair loss, or androgenetic alopecia. It’s the most common type of hair loss in women, affecting up to 38% of women overall, and PCOS adds higher androgen levels to the mix: in a meta-analysis of 18 studies, about 23% of women with PCOS had female pattern hair loss, although the certainty of that estimate was low.

Why sensitivity matters as much as hormone levels

Not every follicle reacts to androgens in the same way, and genes influence how sensitive yours are. That’s why some women with PCOS keep a full head of hair, while many women with normal androgen levels develop thinning: in most women with female pattern hair loss, testosterone is normal. The international PCOS guideline reflects this: female pattern hair loss on its own, without extra hair growth elsewhere, is only a weak predictor of high androgens. And unlike in men, there’s no evidence yet that overproduction of DHT itself drives the pattern in women.

That doesn’t make it any less important. The guideline says hair loss should be taken seriously whatever it looks like on examination, because of its psychological impact, and in one questionnaire study, about 70% of women with female pattern hair loss said they were very to extremely upset about it.

If you’re wondering where insulin fits in, high insulin is thought to push the ovaries to make more androgens, which is one reason they tend to run higher in PCOS. We explain that in our article on insulin resistance and PCOS and look at testosterone itself in our article on PCOS and high testosterone.

Is it PCOS hair loss, or something else?

Not all thinning hair is female pattern hair loss, and PCOS can overlap with other causes, so it’s worth sorting out what’s going on before choosing a treatment.

Gradual thinning versus sudden shedding

Female pattern hair loss progresses slowly, as a widening part or thinner crown. A different pattern, called telogen effluvium, is sudden, diffuse shedding that starts about two to three months after a trigger. In it, a large share of your hairs move into the resting phase at once and shed together. Triggers include illness, surgery, childbirth, some medications, thyroid problems, severe protein or calorie restriction, and, less certainly, emotional stress.

Most acute cases settle within about six months once the trigger is gone. Severe calorie restriction is the trigger that matters most in PCOS, because crash dieting is a common response to weight advice, and very low-calorie eating can set off shedding that has nothing to do with androgens. It’s one more reason the guideline favors flexible, sustainable eating over restriction, which we cover in our PCOS diet article.

Other causes a clinician may check

Both an overactive and an underactive thyroid are linked to hair shedding, and the shedding generally reverses once thyroid levels are back to normal. Low iron has also been linked to hair loss, although how strongly is debated. The hormone-specialist expert report recommends considering thyroid, iron, vitamin D, zinc, and prolactin tests in women with female pattern hair loss, and because the PCOS guideline already recommends excluding thyroid disease when diagnosing PCOS, it’s reasonable to ask whether yours have been checked.

It’s worth having your iron tested before taking supplements. As Harvard Health notes, extra iron won’t help if your levels are normal, and it can cause stomach upset and constipation.

What can help with PCOS hair loss

Once you have a clearer picture of what’s behind your hair loss, the next question is what to do about it. Treatment takes patience, because hair grows slowly and most options need several months to show anything. Some work on the follicle directly, and others work on the hormones behind it.

Minoxidil: the one option approved for female pattern hair loss

Minoxidil is a medicine you apply to your scalp (sold as Rogaine and in generic versions). It isn’t fully understood how it works, but it appears to stimulate the follicles directly rather than acting as a hormone treatment. It’s the only medicine approved by the FDA for female pattern hair loss, available without a prescription in 2% and 5% strengths according to the American Academy of Dermatology (AAD), and a hormone-specialist expert report on female pattern hair loss and androgen excess treats it as the first step.

Hair grows slowly, so expect to wait. You may notice extra shedding in the first two to eight weeks, which settles as new hairs start to grow, and most people need to use it daily for six to 12 months to know how well it’s working. The expert report suggests at least 12 months for the best results. It can produce some new growth of fine hair in some, but not all, women, and it can’t restore the full density of the lost hair, according to Harvard Health. You also have to keep using it: if you stop, you lose its benefits and gradually notice more shedding.

The most common side effect is an irritated scalp, with dryness, scaling, itching, or redness, and if that happens, the AAD advises stopping and seeing your dermatologist. Minoxidil can also cause hair to grow on the cheeks or forehead, which is more likely with the 5% strength, and applying it only to your scalp and washing your face afterward helps limit this. Avoid minoxidil if you’re pregnant, planning to become pregnant, or breastfeeding, because studies in pregnant animals have shown it can harm a developing baby, and traces may pass into breast milk.

The combined pill and anti-androgens

The combined pill contains two hormones, estrogen and a progestin. In PCOS it’s the guideline’s first-line medication for hormone-driven features, mainly irregular cycles and unwanted hair growth, because it raises SHBG (a protein that binds testosterone and keeps it inactive) and reduces the ovaries’ androgen production. For scalp hair loss, the guideline says an anti-androgen could be tried alongside it, so the pill is best thought of as the hormonal groundwork rather than a hair treatment on its own.

The pill isn’t right for everyone, and the guideline says its risks and contraindications (reasons it may not be suitable) need an individual discussion with your clinician. It also doesn’t recommend a specific formulation, and because it’s contraception, it isn’t an option if you’re trying to conceive. Oral contraceptives are also among the medicines that can occasionally trigger temporary shedding, usually starting around three months in, and changing the dose can too, so it’s best not to judge a change too early.

Anti-androgens are medicines that reduce the effects of androgens on your body. The guideline says they could be tried alongside the pill for hair loss, while acknowledging a lack of evidence in women with PCOS, and the expert report suggests adding them to minoxidil when hair loss is severe or androgen levels are high. They tend to be considered for women with more marked thinning or clear signs of high androgens, such as extra hair growth.

Like minoxidil, they’re slow: dermatologists say prescription hair-loss medicines need six to 12 months to judge, and if there’s no regrowth within 12 months, the medicine isn’t going to work for you. The hair that grew is generally lost again within about three to four months of stopping.

Anti-androgens are used off-label in PCOS, and all of the prescription options can cause birth defects, including genital abnormalities in a male baby. That means none is an option if you’re pregnant or planning to become pregnant, and the AAD advises premenopausal women to use effective birth control while taking them. Spironolactone appears to carry a lower risk of side effects at the doses typically used, though it can cause dizziness, excess thirst, and fatigue, and you should tell your clinician about any kidney or adrenal problems. Finasteride, flutamide, and bicalutamide carry liver risks.

Metformin, inositol, and supplements

The guideline recommends metformin primarily for metabolic features and notes that inositol offers limited clinical benefits, so neither is positioned as a hair treatment.

Biotin is the supplement most associated with hair, but in most studies, supplements like it had no effect on hair growth or thickness. The FDA has also warned that biotin can distort lab results, and it can make thyroid tests misleading and affect the troponin test used to diagnose heart attacks, so tell your clinician before blood tests if you take it. Platelet-rich plasma injections, which use platelets from your own blood, show early promise, but more studies are needed to know whether they’re safe and effective.

What the research can’t tell us yet

Most of the evidence for hair loss treatments comes from women with female pattern hair loss in general, not from women with PCOS specifically, which is why treatment is usually tailored. A 2025 review of anti-androgen therapy notes that your age, signs of high androgens, and need for contraception all help determine which option fits, so expect some trial and adjustment with your clinician.

Will it grow back?

It depends on the cause. Shedding from telogen effluvium usually recovers once the trigger resolves. Female pattern hair loss, including PCOS-related hair thinning, is ongoing, so treatment aims to slow it and regrow some hair, and the benefit lasts only while you keep treating it. Treatment also tends to work best when it’s started at the first sign of hair loss, which is one more reason to get it checked early.

When to see a doctor about hair loss

Other causes of hair loss can look a lot like female pattern hair loss, and each needs different treatment, so a diagnosis from a dermatologist is the best starting point. For PCOS, it also helps to involve whoever manages your hormonal care. It’s worth booking an appointment if:

• Your hair loss is sudden or heavy, or your scalp is itchy, painful, or red, or you have bald patches.
• Thinning comes with irregular cycles, acne, or extra hair growth, which together point toward a PCOS evaluation.
• Hair loss or other masculinizing changes, such as a deepening voice, appear or worsen quickly. The guideline says new or rapidly worsening hyperandrogenism needs further investigation, and that overt virilisation isn’t consistent with PCOS.
• You’ve started a new medication or supplement, or changed your eating drastically, in the past few months.
• Hair loss is weighing on your mood. The guideline recommends screening for depression and anxiety in PCOS.

It helps to bring a list of your medications and supplements (including biotin), a timeline of when you noticed changes, and photos in consistent light. Clinicians can track female pattern hair loss with visual scales and monitor it during treatment, and you can ask about thyroid and iron tests and whether your PCOS treatment plan could address your hair too.

Giving yourself time to find what works

Hair changes can feel very personal, and wanting to do something about them is completely reasonable. The guideline itself treats hair loss as important however it looks to anyone else.

What tends to work best is a steady, one-step-at-a-time approach: work out what’s behind it, start with one treatment, and give it long enough to judge fairly. Hair responds slowly, so progress is measured in months, and photos taken every couple of months in the same light are easier to judge than looking in the mirror each day.

There’s no single fix, and some treatments only work while you keep using them. But the right plan, chosen with your clinician, can help slow the thinning and, for many women, bring some hair back.

This article is for general education and does not replace advice from a qualified healthcare provider or dermatologist.

References

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463. Monash University guideline summary (2023): https://www.monash.edu/__data/assets/pdf_file/0003/3371133/PCOS-Guideline-Summary-2023.pdf. Terminology update (June 2026): https://www.monash.edu/medicine/mchri/pcos/guideline
2. Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: new name to improve diagnosis and care of condition affecting 170 million women worldwide. Press release, 12 May 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
3. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. doi:10.7759/cureus.8320
4. Harvard Health Publishing. Treating female pattern hair loss. Reviewed 8 April 2024. https://www.health.harvard.edu/healthy-aging-and-longevity/treating-female-pattern-hair-loss
5. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759-3781. doi:10.1111/jocd.14537
6. Vujovic A, Del Marmol V. The female pattern hair loss: review of etiopathogenesis and diagnosis. Biomed Res Int. 2014;2014:767628. doi:10.1155/2014/767628
7. Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11(4):e9860. doi:10.5812/ijem.9860
8. Rayner DG, McMullen E, Mundle K, Pham M, Sibbald C, Donovan J. Bi-directional association between female pattern hair loss and polycystic ovary syndrome: a systematic review and meta-analysis. JAAD Int. 2025. doi:10.1016/j.jdin.2025.08.004
9. Carmina E, Azziz R, Bergfeld W, et al. Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875-2891. doi:10.1210/jc.2018-02548
10. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467-520. doi:10.1210/er.2015-1104
11. Ong M, et al. Antiandrogen therapy for the treatment of female pattern hair loss: a clinical review of current and emerging therapies. J Am Acad Dermatol. 2025. https://www.jaad.org/article/S0190-9622(25)00722-4/abstract. PubMed: https://pubmed.ncbi.nlm.nih.gov/40345536/
12. American Academy of Dermatology. Thinning hair and hair loss: could it be female pattern hair loss? Last updated 13 December 2022. https://www.aad.org/public/diseases/hair-loss/types/female-pattern
13. Influence of biotin nutritional supplementation on laboratory testing: sex and gender impact. HealthManagement. 2020;20(6):482-484. https://healthmanagement.org/c/women/issuearticle/117182
14. U.S. Food and Drug Administration. Biotin interference with troponin lab tests: assays subject to biotin interference (content current as of 21 June 2022). https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference. Updated safety communication, “The FDA warns that biotin may interfere with lab tests” (November 2019; archived copy): https://downloads.regulations.gov/FDA-2019-D-1876-0015/content.pdf